Trial NCT03324282

View at ClinicalTrials.gov 
Org. Study IDs: CHUBX 2016/33

Last trial update was posted on 2022-05-03

MeSH Interventions

Avelumab

MeSH Conditions

Carcinoma Urinary Bladder Neoplasms

Other Conditions

Bladder Carcinoma

Stopping Reasons

ANSM's refusal to validate ATU requests for avelumab in bladder cancer, Decrease in recruitment, Most investigators would like to offer avelumab for maintenance, Absence of benefit to the chemo-immuno combination (pembro+gem-platinum) in phase III

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID